BYRN leadership overhaul: what Conn Davis’s consumer goods background signals for Byrna Technologies’ next growth phase
Byrna Technologies (BYRN) names Conn Davis CEO as founder Bryan Ganz retires. What the hire signals for strategy, M&A, and a stock near its 52-week low. Read more.
Theravance Biopharma (NASDAQ: TBPH) drops rare disease drug after Phase 3 failure triggers strategic review
Theravance Biopharma drops its rare disease drug after a Phase 3 failure. Explore what this means for NASDAQ: TBPH and biotech investors.
Honeywell International Inc. (NASDAQ: HON) sets Q3 2026 debut for Honeywell Aerospace spin-off as breakup strategy advances
Honeywell International Inc. will spin off Honeywell Aerospace in Q3 2026. Discover what the separation means for HON stock and aerospace markets.
Is Merck & Co., Inc. embedding artificial intelligence at the core of its oncology strategy through Tempus AI integration?
Merck expands its Tempus AI collaboration to embed artificial intelligence into oncology research. What this means for MRK, TEM, and precision medicine.
AeroVironment (Nasdaq: AVAV) shares rebound on Space Force SCAR contract update as renegotiation talks continue
AeroVironment (AVAV) shares rise 6% as the company confirms Space Force SCAR contract talks. Read what the renegotiation means for backlog and outlook.
uniQure (NASDAQ: QURE) sinks after FDA mandates Phase III trial for Huntington’s therapy AMT-130
uniQure (QURE) plunges after FDA demands a Phase III trial for AMT-130 in Huntington’s disease. What this means for valuation and next steps.
What Sanjiv Gupta’s appointment as Graco Inc CFO could mean for capital allocation and shareholder returns
Graco Inc appoints Sanjiv Gupta as CFO. Discover what this means for capital allocation, investor sentiment, and industrial sector competition. Read more.
Rio Tinto (RIO) advances North American gallium supply chain with C$18.9m Ottawa support
Rio Tinto secures C$18.9M in Canadian funding for a Quebec gallium project. Discover what this means for critical minerals and semiconductor supply chains.
RadNet Inc. (NASDAQ: RDNT) strengthens clinical AI strategy with Gleamer acquisition and 46–56% Digital Health growth forecast
RadNet Inc. (RDNT) targets 17–19% imaging growth and $140M digital ARR after acquiring Gleamer. See what this means for AI in radiology.
How OpenAI’s Pentagon contract exposed fault lines in AI governance and national security strategy
OpenAI’s Pentagon deal sparks backlash after Sam Altman admits it was rushed. Discover what this means for AI policy, defense contracts, and rivals.